Download

Full Text

• Saiz, M., Nunez, J.I., Jimenez-Clavero, M.A., Baranowski, E., Sobrino, F., Foot-and-mouth disease virus: biology and prospects for disease control. Microb. Infect. 4 (2002), 1183–1192.
• Krystynak, R.H., Charlebois, P.A., The potential economic impact of an outbreak of foot-and-mouth disease in Canada. Can. Vet. J. 28 (1987), 523–527.
• De Clercq, K., Koenen, F., Strobbe, R., Debecq, J., Simultaneous vaccination of piglets against foot-and-mouth disease and classical swine fever. Vet. Microbiol. 20 (1989), 215–221.
• Kleyman, T.R., Cragoe, E.J., Amiloride and its analogs as tools in the study of ion transport. J. Membr. Biol. 105 (1988), 1–21.
• Levi, L.I., Gnadig, N.F., Beaucourt, S., McPherson, M.J., Baron, B., Arnold, J.J., Vignuzzi, M., Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Pathog., 6, 2010, e1001163.
• Harrison, D.N., Gazina, E.V., Purcell, D.F., Anderson, D.A., Petrou, S., Amiloride derivatives inhibit coxsackievirus B3 RNA replication. J. Virol. 82 (2008), 1465–1473.
• Gazina, E.V., Smidansky, E.D., Holien, J.K., Harrison, D.N., Cromer, B.A., et al. Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase. J. Virol. 85 (2011), 10364–10374.
• Harrison, D.N., Gazina, E.V., Purcell, D.F., Anderson, D.A., Petrou, S., Amiloride derivatives inhibit coxsackievirus B3 RNA replication. J. Virol. 82 (2008), 1465–1473.
• Ewart, G.D., Mills, K., Cox, G.B., Gage, P.W., Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu. Eur. Biophys. J. 31 (2002), 26–35.
• Kim, C.G., Lemaitre, V., Watts, A., Fischer, W.B., Drug-protein interaction with Vpu from HIV-1: proposing binding sites for amiloride and one of its derivatives. Anal. Bioanal. Chem. 386 (2006), 2213–2217.
• Premkumar, A., Horan, C.R., Gage, P.W., Dengue virus M protein C-terminal peptide (DVM-C) forms ion channels. J. Membr. Biol. 204 (2005), 33–38.
• Premkumar, A., Wilson, L., Ewart, G.D., Gage, P.W., Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett. 557 (2004), 99–103.
• Gazina, E.V., Harrison, D.N., Jefferies, M., Tan, H., Williams, D., Anderson, D.A., Petrou, S., Ion transport blockers inhibit human rhinovirus 2 release. Antivir. Res. 67 (2005), 98–106.
• Li, S.F., Gong, M.J., Xie, Y.L., Shao, J.J., Zhao, F.R., Zhang, Y.G., Chang, H.Y., A novel type I interferon, interferon alphaomega, shows antiviral activity against foot-and-mouth disease virus in vitro. Microb. Pathog. 127 (2019), 79–84.
• James, A.D., Rushton, J., The economics of foot and mouth disease. Rev Sci Tech 21 (2002), 637–644.
• Newman, J., Asfor, A.S., Berryman, S., Jackson, T., Curry, S., Tuthill, T.J., The cellular chaperone heat shock protein 90 is required for foot-and-mouth disease virus capsid precursor processing and assembly of capsid pentamers. J. Virol., 92, 2018.
• Holien, J.K., Gazina, E.V., Elliott, R.W., Jarrott, B., Cameron, C.E., Williams, S.J., Parker, M.W., Petrou, S., Computational analysis of amiloride analogue inhibitors of coxsackievirus B3 RNA polymerase. J. Proteomics. Bioinform. Suppl, 9, 2014, 004.